NEW PRODUCT RELEASE: LeviCell 96 High-Throughput System
NEW PRODUCT RELEASE: LeviCell 96 High-Throughput System
Harness magnetic levitation to produce standardized, high-viability organoids and spheroids at scale — reducing formation time from days to hours.
As organoid technologies transition from laboratory proofs-of-concept to clinical and industrial deployment, persistent challenges in reproducibility and scalability have emerged as major barriers.
Batch-to-batch variability from animal-derived ECMs like Matrigel — with undefined molecular composition and poorly controlled mechanical properties — leads to significant differences in organoid size, morphology, and function across experiments and labs.
High-throughput drug screening requires hundreds to tens of thousands of organoids per run. Conventional low-productivity culture methods simply cannot generate enough uniform organoids per unit area to meet these demands.
Conventional organoid culture processes rely on manual handling — repeated pipetting, media exchange, and sample manipulation — making them impractical for GMP compliance and blocking the path to standardized clinical-grade manufacturing.
LevitasBio's Selective Arrayed Levitation Technology uses paramagnetic media and precision magnet arrays to gently separate, enrich, and culture cells — without labels, without centrifugation, without compromise.
No antibodies, no beads, no reagent interference
Process 96 samples simultaneously for true throughput
Gravity-based separation removes >90% of debris
Formation time reduced from 72 hrs to 2 hrs
Validated across multiple cell types and organoid models, delivering consistent results with minimal hands-on time.
See the dramatic difference magnetic levitation makes vs the current methods.
From drug screening to assembloid engineering, the LeviCell 96 enables workflows that were previously impractical.
Rapid, hands-free production of spheroids with consistent shape, size, and density. Magnetic levitation accelerates formation from days to just 2 hours, with built-in viability monitoring.
Monitor cell-to-cell interactions and drug response in real time at single-cell resolution. Density changes reveal viability shifts minutes after compound exposure — no endpoint assay required.
Build complex, multi-layered organoids by sequentially adding cell types during levitation. Engineer assembloids that recapitulate inter-tissue interactions for advanced disease modeling.
Add cell suspension to LeviCell 96 wells with paramagnetic media
Viable cells rise and cluster at the equilibrium plane in minutes
Harvest enriched organoids ready for downstream analysis
The only 96-well magnetic levitation platform designed for organoid and spheroid workflows. Process whole or dissociated organoids with unmatched throughput and gentleness.
See how the LeviCell 96 can accelerate your research — from drug screening to assembloid engineering. Our team will customize a demo for your specific application.
